---
title: "Weekly Recap | Klarna -7.4%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302172016.md"
description: "Klarna (KLAR) fell 7.4% this week to close at $13.02, underperforming the S&P 500, which slipped 1.95% over the same stretch. The stock traded with a heavy tone from the open: it started Monday (Oct 12) at $14.054 and briefly touched $14.155 before fading. Tuesday (Oct 13) closed at $13.38, Wednesday (Oct 14) tested intraday lows near $12.88, Thursday (Oct 15) rebounded to $13.51, and Friday (Oct 16) fell back to $13.02, printing the week’s low at $12.845. Weekly amplitude came to 9."
datetime: "2026-10-17T07:25:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302172016.md)
  - [en](https://longbridge.com/en/news/302172016.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302172016.md)
generator: "portal-rs"
---

# Weekly Recap | Klarna -7.4%, most brokers rate it buy

## The Week

Klarna (KLAR) fell 7.4% this week to close at $13.02, underperforming the S&P 500, which slipped 1.95% over the same stretch. The stock traded with a heavy tone from the open: it started Monday (Oct 12) at $14.054 and briefly touched $14.155 before fading. Tuesday (Oct 13) closed at $13.38, Wednesday (Oct 14) tested intraday lows near $12.88, Thursday (Oct 15) rebounded to $13.51, and Friday (Oct 16) fell back to $13.02, printing the week’s low at $12.845. Weekly amplitude came to 9.32%, with turnover sitting slightly above the recent daily median.

## Key Events

The week’s corporate news centred on payment partnerships. On Monday, Klarna partnered with The White Company to offer flexible payments on homeware purchases; a separate Quant Rating list of top and bottom financial stocks also featured the name. Tuesday brought Ecommpay adding Klarna to its checkout options. Thursday saw Klarna partner with Marks & Spencer to offer interest-free payments online. Three of the four in-week items point to new merchant or platform integrations, largely concentrated in UK retail payment flows.

## Analyst Ratings

Across 24 covering institutions, 9 rate the stock a buy, 1 overweight, and 14 hold; there are no underweight or sell ratings. The consensus rating is buy, with a consensus target of $19.25, about 47.9% above the latest price. The target range is wide, from a low of $13 to a high of $38.3, reflecting meaningful dispersion on valuation. By industry rank, Klarna sits 11th among 45 names in transaction and payment services.

## The Week Ahead

Tuesday (Oct 20) brings US housing starts and building permits data, with prior readings at 1.275 and 1.403 respectively. Wednesday (Oct 21) adds EIA weekly crude and Cushing crude inventory numbers, with priors of -8.557 and 1.862. These macro prints will offer a read on consumer and housing momentum that feeds into payment activity. No company-specific earnings are on the calendar for next week.

## In Short

The week’s signals lean positive on analyst coverage but cautious on price action and flows. Broker ratings skew towards buy, with no sell or underweight calls and a consensus target nearly 50% above spot. At the same time, the stock trades at roughly 3.76x book, with negative earnings keeping P/E in the red. The latest session showed large-lot money turning net seller against net buying in smaller-size flows, and a very wide target range hints at low conviction on the path to those levels. The setup going forward depends on whether macro data stabilises the risk appetite for payment names and whether the large-lot selling persists.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [KLAR.US](https://longbridge.com/en/quote/KLAR.US.md)

## Related News & Research

- [Klarna partners with SQUIRE to offer flexible payments at US barbershops](https://longbridge.com/en/news/303394896.md)
- [Ecommpay adds Klarna to payment platform checkout options](https://longbridge.com/en/news/301688942.md)
- [Key facts: Holley Narrows 2026 Outlook; Sales Up 9%; SXTH Element Acquires](https://longbridge.com/en/news/304753500.md)
- [Kodiak Sciences (KOD) Could Be 23% Undervalued On Its Retina Pipeline Story](https://longbridge.com/en/news/304752600.md)
- [VIR: ECLIPSE 1 met both key endpoints, with 79.2% achieving HDV RNA TND at Week 48](https://longbridge.com/en/news/304773968.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**